Get started
EEE

EGETIS THERAPEUTICS AB

No trades
See on Supercharts
Overview Financials News Discussions Technicals
Forecast

Price target

11.720.000.00%
The 5 analysts offering 1 year price forecasts for EGTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to EGTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Frequently Asked Questions


EGTX EPS for the last quarter is −0.26 SEK despite the estimation of −0.30 SEK. In the next quarter EPS is expected to reach −0.32 SEK. Track more of EGETIS THERAPEUTICS AB financials and stay on top of what is up with the company.
In the next quarter EGETIS THERAPEUTICS AB revenue is expected to reach ‪13.83 M‬ SEK. Check out EGETIS THERAPEUTICS AB revenue and earnings and make informed decisions.
According to analysts, EGTX price target is 11.72 SEK with a max estimate of 16.60 SEK and a min estimate of 6.00 SEK. Check if this forecast comes true in a year, meanwhile watch EGETIS THERAPEUTICS AB stock price chart and keep track of the current situation with EGTX news and stock market news.
We've gathered opinions of 5 analysts rating EGTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.